Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: School of Medicine and Royal Perth Hospital Unit
Location: Level 3, Rear 50 Murray Street, Perth, WA
Lead Doctors: Dr Natalie Ward   
Ethics Committee: Reviewed and approved by the Western Australia Human Research Ethics Committee

Background

Type 2 Diabetes is the fastest growing chronic disease in Australia and has reached epidemic status. Nearly one in four Australian adults is at risk or has already developed the condition. While symptoms can go unnoticed as the disease develops gradually, approximately one in three people with prediabetes will develop type 2 diabetes.

The School of Medicine and Pharmacology at the Royal Perth Hospital  is conducting a research study on protein rich Lupin and its effect on type 2 diabetes. Participants who have type 2 diabetes will be adding Lupin into their diet with the goal of lowering the need for additional medications and medical intervention.

Benefits of Participation

• You could see a reduction in fasting blood glucose levels.
• You will receive the study supplement at no extra cost.
• You could experience possible weight loss.
• You could experience reductions in your high blood pressure.
• You could see future improvements in your type 2 diabetes management.
• You could lower your required amount of doctor visits.
• You will be helping to advance medical research.

Your Rights

• Your records relating to this study and any other information received will be kept strictly confidential.
• Upon completion, the results of the study will be shared with you.
• Qualified medical professionals will supervise your participation.
• You will be able to withdraw from the study at any time.

Who Can Participate?

• Men and women aged 40-70
• Whom have been diagnosed with type 2 diabetes